2m 2m 2m 2m 2m 2m 2m
AMYLYX PHARM (AMLX)
NASDAQ
$31.62$0.00 (0.00%)
Price as of Sep 11, 2026 7:51 PM EDT- $3.5BMarket Cap
- 171.42%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
AMYLYX PHARM (AMLX)
$31.62$0.00 (0.00%)
AMLX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $31.62 | ||
Change | -$0.47 (-1.46%) | ||
Open | $32.09 | ||
High | $33.00 | ||
Low | $31.37 | ||
Previous Close | $32.09 | ||
Volume | 1,712,745 | ||
30-Day Average Volume | 3,526,736 | ||
1-Week Change | -7.27% | ||
1-Month Change | 33.81% | ||
1-Year Change | 171.42% | ||
3-Year Change | 55.92% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 111.4M | ||
Total Assets | $264.6M | ||
Market Cap | $3.5B | ||
Enterprise Value | $3.5B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$43.4M | ||
Free Cash Flow | -$31.4M | ||
EBIT | -$43.4M | ||
EBITDA | -$43.4M | ||
Net Working Capital | $235.2M | ||
EPS | -$0.39 | ||
Enterprise Value/EBITDA | -80 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 15 | ||
P/E | -81 | ||
PEG | 15 | ||
Price/Free Cash Flow | -112 | ||
Price/Operating Cash Flow | -112 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 03/28/2018 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue